N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

STarting incrEmental Prescription of Peritoneal Dialysis

Sponsor: The University of Queensland • ClinicalTrials.gov ID: NCT06642597

Registry updated: 2026-10-15
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.

Interventions

  • Incremental PD (Other)
    Incremental PD: Commence PD using goal-directed PD prescription ≤14 exchanges/week for continuous ambulatory PD (CAPD) or ≤21 exchanges/week for automated PD (APD) with no day dwell until an indication for increase in the PD dose (trigger point) is reached.
  • Full dose PD (Other)
    Full dose PD: Commence with 24 hours, 7 days/week PD (i.e., CAPD ≥28 exchanges/week or APD (overnight) with day dwell (i.e., no dry abdomen)).

Eligibility criteria

Inclusion Criteria: * adults (≥18 years) commencing PD as their first dialysis therapy (and been on dialysis for \<1 month) * able to give informed consent Exclusion Criteria: * urine output \<0.5L/day * previous kidney transplant * unlikely to be on dialysis for ≥1 year. * known or planned pregnancy during the trial

Conditions

Peritoneal Dialysis (PD) Kidney Failure

Locations

  • Blacktown — Blacktown, New South Wales, Australia
  • John hunter Hospital — Newcastle, New South Wales, Australia
  • Wollongong Hospital — Wollongong, New South Wales, Australia
  • Princess Alexandra Hospital — Brisbane, Queensland, Australia
  • Eastern Health — Box Hill, Victoria, Australia
  • Waitemata — Auckland, New Zealand
  • Hallym University Sacred Heart Hospital — Chuncheon, Gangwon-do, South Korea
  • Kyungpook National University Chilgok Hospital — Daegu, South Korea
  • Kyungpook National University — Daegu, South Korea
  • Taichung Veterans General Hospital — Taichung, Xitun District, Taiwan
  • Banphaeo General Hospital — Ban Phaeo, Changwat Samut Sakhon, Thailand
  • Nakhon Pathom Hospital — Nakhon Pathom, Mueang Nakhon Pathom District, Thailand
  • Samut Prakan Hospital — Mueang Samut Prakan, Mueang Samut Prakan District, Thailand
  • King Chulalongkorn Memorial Hospital — Bangkok, Pathum Wan, Thailand
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record